Rhabdomyolysis as a Predominant Multisystem Serious Immune-Related Adverse Event Induced by Sintilimab: A Case Report and Literature Review
Qingyuan Duan, Xueying Zhang, Minjie Li · 2025
Read Rhabdomyolysis as a Predominant Multisystem Serious Immune-Related Adverse Event Induced by Sintilimab: A Case Report and Literature Review by Qingyuan Duan, Xueying Zhang, Minjie Li (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12766318.txt.
Description
Qingyuan Duan, Xueying Zhang, and Minjie Li report a case in which a cancer drug caused grave harm across many parts of the body. Their 2025 paper centers on sintilimab, a drug that frees the immune system to fight cancer. Such drugs can also turn the immune system on healthy tissue.
The patient had lung cancer that had spread to the brain. After treatment, muscle broke down across the body, and the heart muscle and other muscle were inflamed. The liver, thyroid, and adrenal glands were hit at the same time. Strong steroid treatment brought clear gains in the patient's signs and test results. The authors pair the case with a review of past reports to guide care.
Catalog record
| CREATOR | Qingyuan Duan, Xueying Zhang, Minjie Li |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |